XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating Activities:    
Net loss $ (24,041,605) $ (1,694,608)
Depreciation expense 14,290 7,445
Amortization of debt discount 523,481 325,399
Gain from short-term investment (8,323)
Shares issued for services 1,044,144
Finance loss arising from change in terms of convertible notes 21,472,897
Increase in provision for settlements of convertible loan 740,860
Employee option expenses 74,697
Decrease in net liabilities for sale (53,383)
Increase in accounts payable and accrued expenses 51,084 37,656
Decrease in amounts due from related party (34,832)
Increase in deferred revenues 50,000
Increase in accrued interest 26,033
Increase in other receivables 12,222 5,698
Net cash used in continuing operating activities (935,193) (511,652)
Investing Activities:    
Increase in restricted cash (1,184)
Purchase of fixed assets (3,771)
Net cash used in investing activities (4,955)
Financing Activities:    
Proceeds from sale of common stock and warrants (net of issuance expenses) 1,940,950 526,231
Exercise of options 63
Issuance of convertible note 100,000
Net cash provided by financing activities 2,041,013 526,231
Net increase in cash 1,105,820 9,624
Cash and cash equivalents - beginning of period 2,959 4,486
Cash and cash equivalents - end of period 1,108,779 14,110
Non-cash transactions:    
Increase in deferred revenues against short-term investment 50,000
Issuance of shares in respect of proceeds received during 2017 (80,000)
Common stock issued pursuant to convertible note 85,218 10,400
Cashless exercise of warrants $ 153,495